SEC Form 4 · accession 0001104659-26-079865
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Pauls
Director
Period of report
Jun 29, 2026
Accepted (ET)
Jul 1, 2026 · 4:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $154.84 | Jun 29, 2026 | A | 6,000 | A | — | Jun 29, 2036 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1The options vest in 36 equal monthly installments, subject to the Reporting Person's continued service as of each such vesting date.